U.S. stocks ended mixed as investors tracked last-minute diplomatic efforts ahead of the Iran deadline to reopen the Strait of Hormuz. Rising oil prices and inflation concerns weighed on sentiment, while healthcare stocks gained on policy support. Markets remained cautious amid geopolitical uncertainty and mixed economic signals.Read More
Soleno Therapeutics has withdrawn its European drug application. This decision stems from its acquirer, Neurocrine Biosciences, prioritizing the United States market. The drug, Vykat XR, treats a rare genetic disorder. Neurocrine’s CEO confirmed the focus remains on the U.S. launch. This move aligns with a trend of delayed European launches amid U.S. pricing policy shifts.Read More
U.S. health insurer stocks surged after the government announced higher-than-expected Medicare Advantage payment rates for 2027, unlocking over $13 billion in additional payouts. The move eased concerns after weak earlier proposals, with analysts expecting improved margins and renewed investor confidence across the sector amid rising medical costs.Read More
Sebi has granted a temporary relaxation for listed companies struggling to meet Minimum Public Shareholding norms due to Middle East geopolitical tensions. Companies with deadlines between April and September 2026 are exempt from penalties, easing compliance amid volatile markets.Read More
Goldman Sachs sold over 13.82 lakh shares of Cello World via a Rs 55 crore bulk deal at Rs 401 apiece. The stock remained steady despite the transaction but has underperformed over the past year. The company reported flat revenue and a decline in profit in its December quarter results.Read More
European and Asian refiners are paying record high prices of near $150 a barrel for some crude oil grades, far exceeding prices for paper futures, highlighting the worsening supply crisis from the U.S.-Israel war with Iran.Read More
Indian markets extended gains for a fourth session, led by IT, metal and FMCG stocks, with Nifty crossing 23,100. Technical indicators signal bullish momentum and breakout above key levels, though Middle East tensions may drive volatility near resistance at 23,200 in the near term.Read More
Moody’s Ratings on Tuesday revised its outlook on U.S. business development companies (BDCs) to negative from stable, citing rising redemption pressures, higher leverage and weakening access to funding markets.Read More
Maharashtra’s state-owned power distribution firm will be split into two entities under a financial restructuring plan approved by the state cabinet on Tuesday and one of it will be listed on bourses after an IPO is launched within six to nine months of the recast process.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
